Entasis’ Nuzolvence and GSK’s Blujepa are the first antibiotic approvals in gonorrhoea in over 30 years in the US.

GSK secures FDA approval for its oral gonorrhoea drug as EMA backs expanded RSV vaccine and additional respiratory treatments ...

Urinary tract infections (UTIs) commonly occur in people who undergo chemotherapy. The treatment can weaken the immune system and damage barriers, such as the skin and mucous membranes, that help ...

The drug is from a new class of antibiotics, the first new class in decades to be approved as a treatment for gonorrhea, ...

On Friday, the F.D.A. approved a new antibiotic, zoliflodacin, a day after an article published in The Lancet reported that a ...

Five months after signing off on Utility Therapeutics’ Pivya as the first new treatment for uncomplicated urinary tract infections (uUTIs) in more than two decades, the FDA is weighing the pros and ...

A collaborative study, which includes contributions from NDORMS researchers Adam Crowther and supervisor Dario Carugo, ...

A biochemist professor in Nashville helped develop a groundbreaking treatment — the first new drug of its kind in three decades — to treat urinary tract infections that impact many women and some men.

Escherichia coli (E. coli) is a bacteria that commonly causes UTIs. When an infection occurs, doctors prescribe antibiotics to help treat it. E. coli is a type of bacteria that lives in the gut ...

NEW YORK CITY — The U.S. Food and Drug Administration has approved Johnson & Johnson's drug delivery system for patients with a type of bladder cancer, the drugmaker said on Tuesday, offering a ...